review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0899-9007(00)00413-5 |
P698 | PubMed publication ID | 11054608 |
P2093 | author name string | Plata-Salamán CR | |
P2860 | cites work | In vivo IL-1beta-induced modulation of G-protein alphaO subunit subclass in the hypothalamic ventromedial nucleus: implications to IL-1beta-associated anorexia | Q28570397 |
Central nervous system control of food intake | Q29547439 | ||
Feeding and body-weight regulation by hypothalamic neuropeptides--mediation of the actions of leptin | Q33544987 | ||
1998 Curt P. Richter Award. Brain mechanisms in cytokine-induced anorexia | Q33546758 | ||
Cytokine-cytokine interactions and the brain | Q33827916 | ||
Regulation of hunger and satiety in man. | Q36829816 | ||
Immunoregulators in the nervous system | Q37181575 | ||
Antisense oligodeoxynucleotides to G-protein alpha-subunit subclasses identify a transductional requirement for the modulation of normal feeding dependent on G alpha OA subunit | Q38290728 | ||
Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues | Q38322266 | ||
Identification of SOCS-3 as a potential mediator of central leptin resistance | Q38335615 | ||
Interleukin-1beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1beta feedback systems and | Q40646423 | ||
Anorexia during acute and chronic disease | Q41047136 | ||
Cancer cachexia: metabolic alterations and clinical manifestations | Q41371920 | ||
Tumors secreting human TNF/cachectin induce cachexia in mice | Q44211776 | ||
Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1 beta | Q44880489 | ||
Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease | Q47366827 | ||
Meal patterns in response to the intracerebroventricular administration of interleukin-1 beta in rats | Q48142507 | ||
Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats | Q48200039 | ||
Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. | Q48207522 | ||
Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. | Q48236899 | ||
Interleukin-1 (IL-1) receptor type I mediates anorexia but not adipsia induced by centrally administered IL-1beta | Q48617484 | ||
In vivo regulation of the IL-1 beta system (ligand, receptors I and II, receptor accessory protein, and receptor antagonist) and TNF-alpha mRNAs in specific brain regions | Q48888055 | ||
Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. | Q52213375 | ||
The Nutrition Implications of Cardiac Cachexia | Q61663337 | ||
Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice | Q67540660 | ||
Anorexia induced by activators of the signal transducer gp 130 | Q71331319 | ||
Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats | Q71336170 | ||
Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone | Q71460837 | ||
Leptin (OB protein), neuropeptide Y, and interleukin-1 interactions as interface mechanisms for the regulation of feeding in health and disease | Q71818201 | ||
Correlation between food intake and CSF IL-1 alpha in anorectic tumor bearing rats | Q71860300 | ||
The cancer anorexia-cachexia syndrome | Q72681492 | ||
Pathogenesis of cancer anorexia: personal perspective | Q73127910 | ||
Anorexia during acute and chronic disease: relevance of neurotransmitter-peptide-cytokine interactions | Q73411604 | ||
Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats | Q73764128 | ||
Neuropeptide Y counteracts interferon-alpha-induced anorexia | Q78209423 | ||
P433 | issue | 10 | |
P921 | main subject | nervous system | Q9404 |
P304 | page(s) | 1009-1012 | |
P577 | publication date | 2000-10-01 | |
P1433 | published in | Nutrition | Q15762858 |
P1476 | title | Central nervous system mechanisms contributing to the cachexia-anorexia syndrome | |
P478 | volume | 16 |
Q34995229 | A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care |
Q43701471 | Activity of body energy regulatory pathways in inflammation-induced anorexia. |
Q35764044 | An infant with hyperalertness, hyperkinesis, and failure to thrive: a rare diencephalic syndrome due to hypothalamic anaplastic astrocytoma. |
Q37780478 | Animal models of the cancer anorexia–cachexia syndrome |
Q35140230 | Anorexia in cancer: role of feeding-regulatory peptides |
Q88721761 | Appetite during the recovery phase of critical illness: a cohort study |
Q34991293 | Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? |
Q36635641 | CXCL12 sensitizes vago-vagal reflex neurons in the dorsal medulla |
Q37633042 | CXCR4 receptors in the dorsal medulla: implications for autonomic dysfunction |
Q24605567 | Cancer cachexia--pathophysiology and management |
Q54785364 | Cancer incidence and mortality patterns in women with anorexia nervosa. |
Q35214893 | Catabolic mediators as targets for cancer cachexia |
Q47302575 | Critical weight loss in head and neck cancer--prevalence and risk factors at diagnosis: an explorative study |
Q37781997 | Cytokine gene polymorphisms and susceptibility to cachexia |
Q34011011 | Cytokines and cancer anorexia cachexia syndrome |
Q38227496 | Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation |
Q34663975 | Effects of conditioned food aversions on nutritional behavior in humans |
Q35946659 | Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. |
Q47962128 | Effects of tumor necrosis factor α on leptin-sensitive intestinal vagal mechanoreceptors in the cat. |
Q38311787 | Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies |
Q34085744 | Ghrelin: an orexigenic and somatotrophic signal from the stomach |
Q30437812 | How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry |
Q45912797 | Hyperlipidaemia in trypanosomiasis of naturally infected horses: possible cachexia-anorexia syndrome? |
Q42910239 | Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis |
Q37613162 | Hypothalamic inflammation and energy homeostasis: resolving the paradox |
Q36550687 | Hypothalamic integration of immune function and metabolism |
Q48912522 | Hypothalamus transcriptome profile suggests an anorexia-cachexia syndrome in the anx/anx mouse model |
Q48388388 | Impaired voltage-gated K+ channel expression in brain during experimental cancer cachexia. |
Q48459864 | Inducible-NOS but not neuronal-NOS participate in the acute effect of TNF-alpha on hypothalamic insulin-dependent inhibition of food intake |
Q38555790 | Infertility with Testicular Cancer |
Q92826626 | Inflammation, Appetite and Food Intake in Older Hospitalized Patients |
Q28066646 | Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications |
Q35179104 | Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance |
Q36464129 | Influence of proinflammatory cytokine gene polymorphism on childhood obesity |
Q35893437 | Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients |
Q37320958 | Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats |
Q43890306 | Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide |
Q36309946 | Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions |
Q30275676 | Maternal systemic or cord blood inflammation is associated with birth anthropometry in a Tanzanian prospective cohort |
Q42689447 | Meanings of eating deficiencies for people admitted to palliative home care |
Q34764949 | Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia |
Q35001402 | Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed |
Q34590839 | New drugs for the anorexia-cachexia syndrome |
Q34565917 | Nutrition modulation of cachexia/proteolysis |
Q37094850 | Paradoxical surrogate markers of dental injury-induced pain in the mouse |
Q33723662 | Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer |
Q37999707 | Possible involvement of brain-derived neurotrophic factor in eating disorders. |
Q36052673 | Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. |
Q24657720 | Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation |
Q34669261 | Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome |
Q48282089 | Role of cytokines in atypical depression |
Q44833458 | Sex differences in severity of inflammation-induced anorexia and weight loss |
Q55462089 | Successful treatment with a low-dose cisplatin--etoposide regimen for patients with diencephalic syndrome. |
Q35006572 | TNF-alpha and adipocyte biology |
Q33557318 | TRANSLATION OF BRAIN ACTIVITY INTO SLEEP. |
Q36278394 | The cancer cachexia syndrome: a review of metabolic and clinical manifestations |
Q38611320 | The embedded tumour: host physiology is important for the evaluation of tumour growth |
Q96956054 | The impact of acute changes of inflammation on appetite and food intake among older hospitalized patients |
Q36378758 | The origins of cachexia in acute and chronic inflammatory diseases. |
Q79321014 | Thermal hyperalgesia and light touch allodynia after intradermal Mycobacterium butyricum administration in rat |
Q55009518 | Tuberculosis, the Disrupted Immune-Endocrine Response and the Potential Thymic Repercussion As a Contributing Factor to Disease Physiopathology. |
Q47662147 | Tumor necrosis factor alpha in sleep regulation |
Q42445258 | Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons |
Q48568200 | Tumor necrosis factor-alpha activates signal transduction in hypothalamus and modulates the expression of pro-inflammatory proteins and orexigenic/anorexigenic neurotransmitters |